Cyclerion Therapeutics CYCN
$ 3.14
6.58%
Quarterly report 2024-Q3
added 11-14-2024
Cyclerion Therapeutics Financial Statements 2011-2024 | CYCN
Annual Financial Statements Cyclerion Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
6.78 M | 1.13 M | 41.1 M | 101 M | 93.1 M | - | - | - | - | - | - | - | - |
Shares |
2.34 M | 2.17 M | 39.1 M | 32.1 M | 27.4 M | - | - | - | - | - | - | - | - |
Historical Prices |
2.9 | 0.52 | 1.05 | 3.84 | 4.28 | - | - | - | - | - | - | - | - |
Net Income |
-5.26 M | -44.1 M | -51.6 M | -77.8 M | -123 M | -115 M | -93.9 M | - | - | - | - | - | - |
Revenue |
- | 297 K | 3.94 M | 2.3 M | 4.51 M | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 2.3 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-13 M | -18.5 M | -55.2 M | -81.3 M | -125 M | -115 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | -18.5 M | -54.7 M | -79 M | -122 M | -114 M | -92.2 M | - | - | - | - | - | - |
Operating Expenses |
13 M | 18.8 M | 59.1 M | 85.2 M | 130 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
8.13 M | 12.9 M | 20.6 M | 28.8 M | 34.4 M | 27.5 M | 15.1 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Cyclerion Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
2.53 M | 2.51 M | 2.49 M | 2.47 M | 2.44 M | 2.28 M | 2.18 M | 2.18 M | 2.17 M | 2.17 M | 43.4 M | 43.4 M | 43.3 M | 35.7 M | 34.1 M | 34 M | 32.1 M | 27.8 M | 27.7 M | 27.6 M | 27.4 M | 27.4 M | 27.4 K | - | 27.4 K | 27.4 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-723 K | -1.32 M | -1.54 M | - | 7.57 M | -4.18 M | -6.95 M | - | -10.5 M | -13.4 M | -13 M | - | -11.3 M | -16.2 M | -13.4 M | - | -18.8 M | -19.5 M | -20.2 M | - | -27.3 M | -32.3 M | -37.4 M | - | -29.3 M | -29.8 M | -25.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
194 K | - | - | - | - | - | - | - | - | 306 K | 711 K | - | 348 K | 3 M | 62 K | - | 400 K | 749 K | 1.01 M | - | 1.4 M | 1.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-1.13 M | -1.38 M | -1.62 M | - | -6.02 M | -1.86 M | -3.28 M | - | -4.52 M | -13.4 M | -13 M | - | -11.3 M | -16.2 M | -13.4 M | - | -21.8 M | -19.7 M | -20.6 M | - | -28 M | -33.1 M | -37.4 M | - | -29.3 M | -29.8 M | -25.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | - | - | - | - | - | - | -4.45 M | -13.4 M | -12.9 M | - | -10.9 M | -15.8 M | -13.1 M | - | -21.2 M | -19.1 M | -20 M | - | -27.3 M | -32.3 M | -36.9 M | - | -28.9 M | -29.4 M | -24.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
1.32 M | 1.38 M | 1.62 M | - | 6.02 M | 2.4 M | 3.28 M | - | 4.52 M | 13.7 M | 13.7 M | - | 11.6 M | 19.2 M | 13.5 M | - | 22.2 M | 20.4 M | 21.6 M | - | 29.4 M | 34.7 M | 37.4 M | - | 29.3 M | 29.8 M | 25.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
1.24 M | 1.28 M | 1.57 M | - | 2.13 M | 1.53 M | 2.7 M | - | 3.1 M | 3.52 M | 3.95 M | - | 4.6 M | 6.24 M | 5.36 M | - | 8.03 M | 6.63 M | 6.89 M | - | 7.12 M | 8.92 M | 11 M | - | 7.79 M | 7.53 M | 3.77 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency